Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid

Molecular and Cellular Proteomics

Volumn 4, Issue 12, 2005, Pages 2000-2005

  Hu, Yan ^a   Malone, James P ^a   Fagan, Anne M ^a   Townsend, R Reid ^a   Holtzman, David M ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dept of Neurology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEOME;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE MARKER; DISEASE SEVERITY; HUMAN; IMAGE ANALYSIS; PRIORITY JOURNAL; PROTEOMICS; STATISTICAL ANALYSIS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION PROCESS;

CEREBROSPINAL FLUID PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MASS SPECTROMETRY; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 29244434070     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M500207-MCP200     Document Type: Article

References (55)

1. Romeo, M. J., Espina, V., Lowenthal, M., Espina, B. H., Petricoin, E. F., and Liotta, L. A. (2005) CSF proteome: a protein repository for potential biomarker identification. Expert Rev. Proteomics 2, 57-70
2. Rohlff, C. (2000) Proteomics in molecular medicine: applications in central nervous systems disorders. Electrophoresis 21, 1227-1234
3. Han, X., Fagan, A. M., Cheng, H., Morris, J. C., Xiong, C., and Holtzman, D. M. (2003) Cerebrospinal fluid suffatide is decreased in subjects with incipient dementia. Ann. Neurol. 54, 115-119
4. Montine, T. J., Markesbery, W. R., Morrow, J. D., and Roberts, L. J., II (1998) Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Ann. Neurol. 44, 410-413
5. Pratico, D., Clark, C. M., Lee, V. M., Trojanowski, J. Q., Rokach, J.,and FitzGerald, G. A. (2000) Increased 8,12-iso-iPF2α-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity. Ann. Neurol. 48, 809-812
6. Sunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., Bartko, J. J., and Cohen, R. M. (2003) Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. J. Am. Med. Assoc. 289, 2094-2103
7. Sobow, T., Flirski, M., and Liberski, P. P. (2004) Amyloid-β and tau proteins as biochemical markers of Alzheimer's disease. Acta Neurobiol. Exp. (Wars.) 64, 53-70
8. Morris, J. C., and Price, A. L. (2001) Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J. Mol. Neurosci. 17, 101-118
9. Davidsson, P., Westman-Brinkmalm, A., Nilsson, C. L., Lindbjer, M., Paulson, L., Andreasen, N., Sjogren, M., and Blennow, K. (2002) Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients. Neuroreport 13, 611-615
10. Puchades, M., Hansson, S. F., Nilsson, C. L., Andreasen, N., Blennow,K., and Davidsson, P. (2003) Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Brain Res. Mol. Brain Res. 118, 140-146
11. Choe, L. H., Dutt, M. J., Relkin, N., and Lee, K. H. (2002) Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease. Electrophoresis 23, 2247-2251
12. Carrette, O., Demalte, I., Scherl, A., Yalkinoglu, O., Corthals, G., Burkhard, P., Hochstrasser, D. F., and Sanchez, J. C. (2003) A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics 3, 1486-1494
13. Han, D. K., Eng, J., Zhou, H., and Aebersold, R. (2001) Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat. Biotechnol. 19, 946-951
14. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags, Nat. Biotechnol. 17, 994-999
15. Zhang, J., Goodlett, D. R., Quinn, J. F., Peskind, E., Kaye, J. A., Zhou, Y., Pan, C., Yi, E., Eng, J., Wang, Q., Aebersold, R. H., and Montine, T. J. (2005) Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. J. Alzheimer's Dis. 7, 125-133
16. Alban, A., David, S. O., Bjorkesten, L., Andersson, C., Sloge, E., Lewis, S., and Currie, I. (2003) A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3, 36-44
17. Tonge, R., Shaw, J., Middleton, B., Rowlinson, R., Rayner, S., Young,J., Pognan, F., Hawkins, E., Currie, I., and Davison, M. (2001) Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1, 377-396
18. Baker, M. A., Witherdin, R., Hetherington, L., Cunningham-Smith, K., and Aitken, R. J. (2005) Identification of post-translational modifications that occur during sperm maturation using difference in two-dimensional gel electrophoresis. Proteomics 5, 1003-1012
19. Beckner, M. E., Chen, X., An, J., Day, B. W., and Pollack, I. F. (2005) Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies. Lab. Investig. 85, 316-327
20. Sitek, B., Apostolov, O., Stuhler, K., Pfeiffer, K., Meyer, H. E., Eggert, A., and Schramm, A. (2005) Identification of dynamic proteome changes upon ligand-activation of Trk-receptors using two-dimensional fluorescence difference gel electrophoresis and mass spectrometry. Mol. Cell. Proteomics 4, 291-299; Correction (2005) Mol. Cell. Proteomics 4, 1210
21. Seike, M., Kondo, T., Fujii, K., Yamada, T., Gemma, A., Kudoh, S., and Hirohashi, S. (2004) Proteomic signature of human cancer cells. Proteomics 4, 2776-2788
22. Kleno, T. G., Leonardsen, L. R., Kjeldal, H. O., Laursen, S. M., Jensen, O. N., and Baunsgaard, D. (2004) Mechanisms of hydrazine toxicity in rat liver investigated by proteomics and multivariate data analysis. Proteomics 4, 868-880
23. Friedman, D. B., Hill, S., Keller, J. W., Merchant, N. B., Levy, S.E., Coffey, R. J., and Caprioli, R. M. (2004) Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 4, 793-811
24. Evans, C. A., Tonge, R., Blinco, D., Pierce, A., Shaw, J., Lu, Y., Hamzah, H. G., Gray, A., Downes, C. P., Gaskell, S. J., Spooncer, E., and Whetton, A. D. (2004) Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility. Blood 103, 3751-3759
25. Somiari, R. I., Sullivan, A., Russell, S., Somiari, S., Hu, H., Jordan, R., George, A., Katenhusen, R., Buchowiecka, A., Arciero, C., Brzeski, H., Hooke, J., and Shriver, C. (2003) High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics; 3, 1863-1873
26. Morris, J. C. (1997) Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int. Psychogeriatr. 9, 173-178
27. Thompson, E. J. (1988) The CSF Proteins: A Biochemical Approach, pp. 9-26, Elsevier Science Publishing Co., Inc., New York
28. Havlis, J., Thomas, H., Sebela, M., and Shevchenko, A. (2003) Fast-response proteomics by accelerated in-gel digestion of proteins. Anal. Chem. 75, 1300-1306
29. Medzihradszky, K. F., Campbell, J. M., Baldwin, M. A., Falick, A. M., Juhasz, P., Vestal, M. L., and Burlingame, A. L. (2000) The characteristics of peptide collision-induced dissociation using a high-performance MALDI-TOF/TOF tandem mass spectrometer. Anal. Chem. 72, 552-558
30. Chromy, B. A., Gonzales, A. D., Perkins, J., Choi, M. W., Corzett, M.H., Chang, B. C., Corzett, C. H., and McCutchen-Maloney, S. L. (2004) Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins. J. Proteome Res. 3, 1120-1127
31. You, J. S., Gelfanova, V., Knierman, M. D., Witzmann, F. A., Wang,M., and Hale, J. E. (2005) The impact of blood contamination on the proteome of cerebrospinal fluid. Proteomics 5, 290-296
32. Tanzi, R. E., and Bertram, L. (2005) Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120, 545-555
33. Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., Pergamenschikov, A., Lee, J. C., Lashkari, D., Shalon, D., Myers, T. G., Weinstein, J. N., Botstein, D., and Brown, P. O. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet 24, 227-235
34. Scheurle, D., DeYoung, M. P., Binninger, D. M., Page, H., Jahanzeb, M., and Narayanan, R. (2000) Cancer gene discovery using digital differential display. Cancer Res. 60, 4037-4043
35. Hu, Y., Wang, T., Stormo, G. D., and Gordon, J. I. (2004) RNA interference of achaete-scute homolog 1 in mouse prostate neuroendocrine cells reveals its gene targets and DNA binding sites. Proc. Natl. Acad. Sci. U. S. A. 101, 5559-5564
36. Fonteh, A., and Harrington, M. (2002) Importance of proteins that metabolize polyunsaturated fatty acids in the pathogenesis of Alzheimer's disease in the 5th Siena Meeting: From Genome to Proteome: Functional Proteomics, University of Siena (Siena, Italy) September 2-5, 2002, 91
37. Lovell, M. A., Xie, C., Gabbita, S. P., and Markesbery, W. R. (2000) Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. Free Radic. Biol. Med. 28, 418-427
38. Hakala, B. E., White, C., and Recklies, A. D. (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J. Biol. Chem. 268, 25803-25810
39. Sekine, T., Masuko-Hongo, K., Matsui, T., Asahara, H., Takigawa, M., Nishioka, K., and Kato, T. (2001) Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis. Ann. Rheum. Dis. 60, 49-54
40. Perlow, M. J., and Lake, C. R. (1980) Daily fluctuations in catecholamines, monoamine metabolites, cyclic AMP, and γ-aminobutyric acid, in Neurobiology of Cerebrospinal Fluid (Wood J. H., ed) Vol. 1, pp. 63-69, Plenum Press, New York
41. Merched, A., Serot, J. M., Visvikis, S., Aguillon, D., Faure, G., and Siest, G. (1998) Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry. FEBS. Lett. 425, 225-228
42. Serot, J. M., Christmann, D., Dubost, T., and Couturier, M. (1997) Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 63, 506-508
43. Riisoen, H. (1988) Reduced prealbumin (transthyretin) in CSF of severely demented patients with Alzheimer's disease. Acta Neurol. Scand. 78, 455-459
44. Davidsson, P., Ekman, R., and Blennow, K. (1997) A new procedure for detecting brain-specific proteins in cerebrospinal fluid. J. Neural Transm. 104, 711-720
45. Sampaolo, S., Campos-Barros, A., Mazziotti, G., Carlomagno, S., Sannino, V., Amato, G., Carella, C., and Di Iorio, G. (2005) Increased cerebrospinal fluid levels of 3,3′,5′-triiodothyronine in patients with Alzheimer's disease. J. Clin. Endocrinol. Metab. 90, 198-202
46. Blennow, K., Davidsson, P., Wallin, A., Gottfries, C. G., and Svennerholm, L. (1994) Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia. Int. Psychogeriatr. 6, 13-22; discussion 59-60
47. Iqbal, K., and Grundke-lqbal, I. (1997) Elevated levels of tau and ubiquitin in brain and cerebrospinal fluid in Alzheimer's disease. Int. Psychogeriatr.9, 289-296; discussion 317-321
48. Kudo, T., Iqbal, K., Ravid, R., Swaab, D. F., and Grundke-Iqbal, I. (1994) Alzheimer disease: correlation of cerebro-spinal fluid and brain ubiquitin levels. Brain Res. 639, 1-7
49. Skoog, I., Vanmechelen, E., Andreasson, L. A., Palmertz, B., Davidsson, P., Hesse, C., and Blennow, K. (1995) A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. Neurodegeneration 4, 433-442
50. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., Jacobson, A., and Pappin, D. J. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3, 1154-1169
51. Berg, L., McKeel, D. W., Jr., Miller, J. P., Storandt, M., Rubin, E.H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., Price, J. L., Gearing, M., Mirra, S. S., and Saunders, A. M. (1998) Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch. Neurol. 55, 326-335
52. Ganguli, M., Rodriguez, E., Mulsant, B., Richards, S., Pandav, R., Bilt, J. V., Dodge, H. H., Stoehr, G. P., Saxton, J., Morycz, R. K., Rubin, R. T., Farkas, B., and DeKosky, S. T. (2004) Detection and management of cognitive impairment in primary care: The Steel Valley Seniors Survey. J. Am. Geriatr. Soc. 52, 1668-1675
53. Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., Pfeiffer, E., Sano, M., van Dyck, C. H., and Thal, L. J. (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 352, 2379-2388
54. Hulette, C. M., Welsh-Bohmer, K. A., Murray, M. G., Saunders, A. M., Mash, D. C., and McIntyre, L. M. (1998) Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J. Neuropathol. Exp. Neurol. 57, 1168-1174
55. Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergstrom, M., Savitcheva, I., Huang, G. F., Estrada, S., Ausen, B., Debnath, M. L., Barletta, J., Price, J. C., Sandell, J., Lopresti, B. J., Wall, A., Koivisto, P., Antoni, G., Mathis, C. A., and Langstrom, B. (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 55, 306-319